Sabra Health Care

Sabra Health Care REIT, Inc. engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Sabra Health Care reports strong Q4 performance amidst Enlivant JV challenges

Sabra Health Care showcased improved performance in occupancy rates and revenue growth, with a strategic focus on senior housing opportunities.
Despite challenges from the Enlivant JV impact and market uncertainties, Sabra's strengths in debt management and asset operations position it well for future growth.
Opportunities lie in securing interest rates, expanding in the senior housing sector, and resolving uncertainties around the Enlivant JV for strategic advancement.
Addressing challenges such as transaction market dynamics and maintaining growth momentum will be crucial for Sabra's continued success in the healthcare real estate sector.

Sabra Health Care reports stable Q1 performance amidst market challenges

Sabra Health Care's Q1 2023 performance reflects stability and operational improvements in skilled nursing and senior housing portfolios.
While facing challenges in investment activity and rising debt financing rates, the company is leveraging opportunities in Medicaid rate increases and strategic investments.
Maintaining financial strength and flexibility, Sabra Health Care is poised to navigate market uncertainties and drive operational efficiency.

Sabra Health Care reports robust Q2 performance and eyes 2024 growth

Sabra Health Care's Q2 2023 earnings call highlighted positive performance metrics, ongoing margin recovery efforts, and strategic initiatives to drive occupancy and revenue growth. Despite challenges in the IL segment and market dynamics, the company's strong financial position and focus on portfolio optimization position it well for future opportunities.

Sabra Health Care posts robust Q3 results, eyes growth opportunities

Sabra Health Care's Q3 2023 earnings call reflects strong performance, portfolio stability, and growth potential. Challenges include maintaining coverage ratios and addressing analyst concerns. Opportunities exist in acquisitions, financing, and leveraging portfolio momentum.

Sabra Health Care reports strong Q4 performance and eyes industry growth opportunities

Sabra Health Care showcased strong performance in occupancy and financial metrics, with a focus on operational improvements and growth strategies.
While facing challenges related to occupancy levels and construction costs, the company remains optimistic about industry recovery and growth potential.
Opportunities in the skilled nursing space and sale-leaseback investments present avenues for expansion and strategic development.
Analysts' inquiries and discussions on acquisitions, regulatory issues, and financial guidance reflect a dynamic landscape with potential for strategic advancements.

Sabra Health Care reports solid Q3 performance amidst cautious outlook

Sabra Health Care's Q3 2024 earnings call reflected strong financial performance, strategic focus on quality investments, and cautious outlook on guidance and debt metrics. The company faces competition in skilled nursing but sees opportunities in acquisitions and margin improvement.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

11%-Yielding Sabra Health Care: Plenty Of Headwinds Already Priced In.

11%-Yielding Sabra Health Care: Plenty Of Headwinds Already Priced In

IRVINE, Calif.--(BUSINESS WIRE)-- #1Q23--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 first quarter earnings release on May 3, 2023, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 first quarter results will be held on Thursday, May 4 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572.

Sabra Health Care REIT, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call

Sabra is expected to grow, but it hasn't actually grown much recently. Management's explanations for the lack of growth leave something to be desired.

This Dividend Stock Will Rise by 20%, Per Wall Street. Here's Why You Should Sell It.

AFC Gamma

Dividend yields rise sharply when share prices fall sharply. AFC Gamma might soon see a handful of its interest-bearing loans go into default.

Beware Of These 2 High-Yield Dividend Stocks In 2023

Sabra Health's funds from operations were less than it was paying out in dividends last quarter. Rising labor costs have been weighing on the business lately.

Should You Buy Sabra Health Care REIT for Its 10% Dividend Yield?

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q4 2022 Results Conference Call February 22, 2023 1:00 PM ET Company Participants Lukas Hartwich - SVP, Finance Rick Matros - CEO, President and Chair Talya Nevo-Hacohen - Chief Investment Officer, Treasurer, and EVP Michael Costa - Chief Financial Officer Conference Call Participants Avery Tiras - Citi Juan Sanabria - BMO Capital Markets Vikram Malhotra - Mizuho Rich Anderson - SMBC Joshua Dennerlein - Bank of America Steven Valiquette - Barclays Tayo Okusanya - Credit Suisse John Pawlowski - Green Street Advisors Operator Good day, everyone. My name is Rob, and I will be your conference operator today.

Sabra Health Care REIT, Inc. (SBRA) Q4 2022 Earnings Call Transcript

Sabra (SBRA) delivered FFO and revenue surprises of 2.78% and 2.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Sabra Healthcare (SBRA) Beats Q4 FFO and Revenue Estimates

IRVINE, Calif.--(BUSINESS WIRE)-- #4Q22--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2022. FOURTH QUARTER 2022 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2022 were as follows: Net Loss: $(0.37) FFO: $0.25 Normalized FFO: $0.37 AFFO: $0.34 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.

Sabra Reports Fourth Quarter 2022 Results

IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, will present at the WISE Forum, and other members of the company will attend the WISE Forum on February 28, 2023, at the Rancho Valencia Resort and Spa in Rancho Santa Fe, California.

Sabra Health Care REIT, Inc. to Attend the WISE Forum, 2023 NIC Spring Conference and Citi's 2023 Global Property CEO Conference

Medical REITs are off to a flying start this year, returning 13.8% YTD, as compared to the Equity REIT Index gain of 11.5% and the S&P 500 gain of just 7.8%. This recent outperformance comes in spite of strong headwinds in the form of high labor costs due to a shortage of skilled nurses and waning government fiscal support.

Sabra Health Care: The Patient Is In Stable Condition

Ensign Group

IRVINE, Calif.--( BUSINESS WIRE )--Sabra Health Care REIT, Inc. (“Sabra”, “the Company”) (Nasdaq: SBRA) announced today that since September 30, 2022, the Company has received roughly $185 million of gross proceeds related to previously disclosed disposition activity. In addition, the 24 properties formerly leased to North American (“North American”) have been successfully transitioned to Ensign (“Ensign”) (Nasdaq: ENSG) and the Avamere Family of Companies (“Avamere”).

Sabra Provides Update on Previously Disclosed Disposition Activity and North American Transition

IRVINE, Calif.--( BUSINESS WIRE )--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2022 fourth quarter earnings release on February 21, 2023, after the close of trading.

Sabra Health Care REIT, Inc. Announces Fourth Quarter 2022 Earnings Release Date and Conference Call; Declares Common Dividend

IRVINE, Calif.--( BUSINESS WIRE )--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2022 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid:

Sabra Health Care REIT, Inc. Announces Tax Treatment of 2022 Distributions

AGNC Investment

Armada Hoffler Properties

Brookfield Asset Management

Broadmark Realty Capital Inc.

Blackstone Group

Douglas Emmett

EPR Properties

Equity Commonwealth

Equity Residential

Global Medical REIT

Innovative Industrial Properties

Industrial Logistics Properties

Medical Properties Trust

Annaly Capital

NexPoint Residential Trust

SL Green Realty

Vornado Realty Trust

Vanguard Real Estate ETF

Many high-profile billionaires are loading up on REITs at the moment. I present 5 reasons why REITs are attractive to billionaires and average investors alike.

Billionaires Are Buying REITs (And You Should Too)

IRVINE, Calif.--( BUSINESS WIRE )--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Eliza Gozar, the company's Senior Vice President of Investments, will attend ASHA's 2023 Annual Meeting on January 23 - 25, 2023 at The Westin Kierland in Scottsdale, Arizona.

Sabra Health Care REIT, Inc. to Attend ASHA's 2023 Annual Meeting

IRVINE, Calif.--( BUSINESS WIRE )--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) announced today that it has amended and restated its credit facility, improving its debt maturity profile while keeping capacity and pricing consistent with its prior credit facility.

Sabra Renews and Extends its Credit Facility

IRVINE, Calif.--( BUSINESS WIRE )--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, and other members of the company, will participate virtually in the Capital One Securities 3rd Annual REIT Conference on January 9 - 10, 2023.

Sabra Health Care REIT, Inc. to Participate in the Capital One Securities 3rd Annual REIT Conference and Stifel 2023 Seniors Housing and Healthcare Real Estate Conference

The healthcare REIT cut its payout in 2020, yet its dividend yield remains at elevated levels.

Why Is Sabra Healthcare's Dividend Yield So High?

Digital Realty Trust

Rayonier

Finding the best REITs to buy can lead to great returns if you do it right. One way to do that is by buying high-quality REITs.

The 3 Best REITs to Buy for 2023

Enterprise Products Partners

Analysts expect these supercharged income stocks, with yields of 7.7% and 9.3%, to handily outperform in 2023.

2 Ultra-High-Yield Dividend Stocks With Up to 46% Upside in 2023, According to Wall Street

Brandywine Realty

Broadstone Net Lease

CTO Realty Growth

Highwoods Properties

Hudson Pacific Properties

LTC Properties

National Health Investors

Omega Healthcare Investors

OUTFRONT Media

Simon Property Group

Spirit Realty Capital

Uniti Group

Income-seeking investors are looking at an opportunity to scoop up shares of real estate investment trusts. Stocks in that asset class have become more attractive as prices have fallen and cash flow is improving.

20 dividend stocks with high yields that have become more attractive right now

Sabra Health Care REIT is led by an experienced management team and has made great progress on tenant rent coverage issues. It maintains a healthy balance sheet and expects leverage to improve to the 5.0x range by year-end.

Sabra Health Care: Big 9.6% Yield And Upside Potential

We were looking for a 10% FFO drop in 2022 for Sabra. We appear to be on course for that and new tenant issues have cropped up.

Sabra: 9.5% Yield Comes With High Risks

Kraft Heinz

The yields are high on these two dividend stocks and so are their payout ratios.

Is a Dividend Cut Inevitable for These 2 High-Yielding Stocks?

IRVINE, Calif.--( BUSINESS WIRE )--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company's Chief Investment Officer; Peter Nyland, the company's Executive Vice President of Asset Management; Darrin Smith, the company's Executive Vice President of Investments; and Eliza Gozar, the company's Senior Vice President of Investments, will attend the eighth annual Treatment Center Investment and Valuation Retreat December 5-7, 2022, at the Fairmont Scottsdale Princess in Scottsdale, Arizona.

News for Sabra Health Care Stock (SBRA)